Category: News
Tessa Therapeutics announces new Board Member and increase of recent funding round
SINGAPORE, April 11, 2018 /PRNewswire/ — Tessa Therapeutics, an international clinical stage biopharmaceutical company focusing on cellular immunotherapy treatments for cancer, is delighted to
- 11 04 2018
- |